Citations (61)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Mauro Giovanni Carta, Goce Kalcev, Michele Fornaro & Antonio Egidio Nardi. (2021) Novel experimental and early investigational drugs for the treatment of bipolar disorder. Expert Opinion on Investigational Drugs 30:11, pages 1081-1087.
Read now
Read now
Najwa Taghy, Linda Cambon, Jean-Marie Cohen & Claude Dussart. (2020) Failure to Reach a Consensus in Polypharmacy Definition: An Obstacle to Measuring Risks and Impacts—Results of a Literature Review. Therapeutics and Clinical Risk Management 16, pages 57-73.
Read now
Read now
Taro Kishi, Ikuo Nomura, Kenji Sakuma, Tsuyoshi Kitajima, Kazuo Mishima & Nakao Iwata. (2019) Melatonin receptor agonists—ramelteon and melatonin—for bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials. Neuropsychiatric Disease and Treatment 15, pages 1479-1486.
Read now
Read now
Articles from other publishers (58)
Ana M. Díaz-Zuluaga, Jorge I. Vélez, Mauricio Cuartas, Johanna Valencia, Mauricio Castaño, Juan David Palacio, Mauricio Arcos-Burgos & Carlos López-Jaramillo. (2023) Ancestry component as a major predictor of lithium response in the treatment of bipolar disorder. Journal of Affective Disorders 332, pages 203-209.
Crossref
Crossref
Jorge A. Sanchez Ruiz, Brandon J. Coombes, Richard S. Pendegraft, Aysegul Ozerdem, Susan L. McElroy, Alfredo B. Cuellar-Barboza, Miguel L. Prieto, Mark A. Frye, Stacey J. Winham & Joanna M. Biernacka. (2023) Pharmacotherapy exposure as a marker of disease complexity in bipolar disorder: Associations with clinical & genetic risk factors. Psychiatry Research 323, pages 115174.
Crossref
Crossref
Katja Häkkinen, Wilma Kiander, Heidi Kidron, Markku Lähteenvuo, Lea Urpa, Jonne Lintunen, Kati-Sisko Vellonen, Seppo Auriola, Minna Holm, Kaisla Lahdensuo, Olli Kampman, Erkki Isometsä, Tuula Kieseppä, Jouko Lönnqvist, Jaana Suvisaari, Jarmo Hietala, Jari Tiihonen, Aarno Palotie, Ari V. Ahola-Olli & Mikko Niemi. (2023)
Functional Characterization of Six
SLCO1B1
(OATP1B1) Variants Observed in Finnish Individuals with a Psychotic Disorder
. Molecular Pharmaceutics 20:3, pages 1500-1508.
Crossref
Crossref
Domenico De Berardis, Michele Fornaro & Claudia Carmassi. (2023) Editorial: Comorbidity in bipolar disorder, volume II. Frontiers in Psychiatry 14.
Crossref
Crossref
Andrea Aguglia, Antimo Natale, Laura Fusar-Poli, Andrea Amerio, Alessandra Costanza, Fabio Fesce, Giovanni Battista Gnecco, Margherita Marino, Valeria Placenti, Gianluca Serafini, Eugenio Aguglia & Mario Amore. (2022) Complex polypharmacy in bipolar disorder: Results from a real-world inpatient psychiatric unit. Psychiatry Research 318, pages 114927.
Crossref
Crossref
Aran Tajika, Hikaru Hori, Jun-ichi Iga, Yosuke Koshikawa, Haruhiko Ogata, Yusuke Ogawa, Koichiro Watanabe, Tadafumi Kato, Koji Matsuo & Masaki Kato. (2022) Mood Stabilizers and Antipsychotics for Acute Mania: Systematic Review and Meta-Analysis of Augmentation Therapy vs Monotherapy From the Perspective of Time to the Onset of Treatment Effects. International Journal of Neuropsychopharmacology 25:10, pages 839-852.
Crossref
Crossref
Jan‐Marie Kozicky, Ayal Schaffer, Serge Beaulieu, Diane McIntosh & Lakshmi N. Yatham. (2021) Use of a point‐of‐care web‐based application to enhance adherence to the CANMAT and ISBD 2018 guidelines for the management of bipolar disorder. Bipolar Disorders 24:4, pages 392-399.
Crossref
Crossref
M.S. Reddy, Gundugurthi Prasad Rao, Suresh Kumar, Vijay Seshadri & Phani Prasant. (2022) Clinical characteristics, sociodemographic profile, and treatment pattern of bipolar disorder - A multicenter study from India. Psychiatry Research Communications 2:2, pages 100039.
Crossref
Crossref
João Pedro Aguiar, João Gama Marques, Hubert G. M. Leufkens & Filipa Alves da Costa. (2022) Healthcare Professionals' Views on the Management of Medication Complexities in the Elderly With Mental Health Disorders: A Cross-Sectional Study. Frontiers in Psychiatry 13.
Crossref
Crossref
Chih-Wei Hsu, Shang-Ying Tsai, Ping-Tao Tseng, Chih-Sung Liang, Eduard Vieta, Andre F. Carvalho, Brendon Stubbs, Hung-Yu Kao, Yu-Kang Tu & Pao-Yen Lin. (2022) Differences in the prophylactic effect of serum lithium levels on depression and mania in bipolar disorder: A dose-response meta-analysis. European Neuropsychopharmacology 58, pages 20-29.
Crossref
Crossref
Trang TT. Truong, Chiara C. Bortolasci, Briana Spolding, Bruna Panizzutti, Zoe SJ. Liu, Srisaiyini Kidnapillai, Mark Richardson, Laura Gray, Craig M. Smith, Olivia M. Dean, Jee Hyun Kim, Michael Berk & Ken Walder. (2022) Co-Expression Networks Unveiled Long Non-Coding RNAs as Molecular Targets of Drugs Used to Treat Bipolar Disorder. Frontiers in Pharmacology 13.
Crossref
Crossref
Jennifer Fontaine, Evelyn Chin, Jean-François Provencher, Anthony Rainone, Dana Wazzan, Carmella Roy, Soham Rej, Marie Lordkipanidze & Vincent Dagenais-Beaulé. (2022) Assessing cardiometabolic parameter monitoring in inpatients taking a second-generation antipsychotic: The CAMI-SGA study – a cross-sectional study. BMJ Open 12:4, pages e055454.
Crossref
Crossref
Siu Wa Tang, Wayne H. Tang & Brian E. Leonard. (2021) Treatment-induced mood switching in affective disorders. Acta Neuropsychiatrica 34:2, pages 55-68.
Crossref
Crossref
Anson Chi On Kan, Joe Kwun Nam Chan, Corine Sau Man Wong, Eric Yu Hai Chen & Wing Chung Chang. (2022) Psychotropic drug utilization patterns in pregnant women with bipolar disorder: A 16-year population-based cohort study. European Neuropsychopharmacology 57, pages 75-85.
Crossref
Crossref
Shih-Ku Lin, Shu-Yu Yang, Seon-Cheol Park, Ok-Jin Jang, Xiaomin Zhu, Yu-Tao Xiang, Wen-Chen Ouyang, Afzal Javed, M. Nasar Sayeed Khan, Sandeep Grover, Ajit Avasthi, Roy Abraham Kallivayalil, Kok Yoon Chee, Norliza Chemi, Takahiro A. Kato, Kohei Hayakawa, Pornjira Pariwatcharakul, Margarita Maramis, Lakmi Seneviratne, Sim Kang, Wai Kwong Tang, Tin Oo, Norman Sartorius, Chay-Hoon Tan, Mian-Yoon Chong, Yong Chon Park & Naotaka Shinfuku. (2022) Prescription Patterns for Bipolar Disorder in Asian Countries: Findings from Research on Asian Prescription Pattern-Bipolar Disorder. Clinical Psychopharmacology and Neuroscience 20:1, pages 61-69.
Crossref
Crossref
Keita Tokumitsu, Yasui-Furukori Norio, Naoto Adachi, Yukihisa Kubota, Yoichiro Watanabe, Kazuhira Miki, Takaharu Azekawa, Koji Edagawa, Eiichi Katsumoto, Seiji Hongo, Eiichiro Goto, Hitoshi Ueda, Masaki Kato, Atsuo Nakagawa, Toshiaki Kikuchi, Takashi Tsuboi, Koichiro Watanabe, Kazutaka Shimoda & Reiji Yoshimura. (2021) Real-world clinical predictors of manic/hypomanic episodes among outpatients with bipolar disorder. PLOS ONE 16:12, pages e0262129.
Crossref
Crossref
Borjanka Batinic, Ivan Ristic, Milica Zugic & David S. Baldwin. (2021) Treatment of Symptom Clusters in Schizophrenia, Bipolar Disorder and Major Depressive Disorder With the Dopamine D3/D2 Preferring Partial Agonist Cariprazine. Frontiers in Psychiatry 12.
Crossref
Crossref
Bernardo Dell'Osso, Chiara Arici, Rita Cafaro, Matteo Vismara, Laura Cremaschi, Beatrice Benatti, Monica Macellaro, Caterina Viganò & Terence A. Ketter. (2021) Antidepressants in bipolar disorder: Analysis of correlates overall, and in BD-I and BD-II subsamples. Journal of Affective Disorders 292, pages 352-358.
Crossref
Crossref
Jens Bohlken, Steffi Riedel-Heller, Michael Bauer & Karel Kostev. (2021) Bipolar Disorder and Outcomes of Monotherapy with Lithium, Valproate, Quetiapine, Olanzapine, Venlafaxine, and Citalopram. Pharmacopsychiatry 54:03, pages 126-130.
Crossref
Crossref
Sébastien Brodeur, Hugo Terrisse, Arnaud Pouchon, Ophelia Godin, Bruno Aouizerate, Valerie Aubin, Frank Bellivier, Raoul Belzeaux, Thierry Bougerol, Philippe Courtet, Caroline Dubertret, Sebastien Gard, Emmanuel Haffen, Chantal Henry, Marion Leboyer, Emilie Olié, Paul Roux, Ludovic Samalin, Raymund Schwan, Bruno Etain, Jean-Luc Bosson & Mircea Polosan. (2021) Pharmacological treatment profiles in the FACE-BD cohort: An unsupervised machine learning study, applied to a nationwide bipolar cohort✰. Journal of Affective Disorders 286, pages 309-319.
Crossref
Crossref
Sun-Young Kim, Han-Na Kim, Sang Won Jeon, Weon-Jeong Lim, Soo In Kim, Youn Jung Lee, Se Young Kim & Yong-Ku Kim. (2021) Association between genetic variants of the norepinephrine transporter gene (SLC6A2) and bipolar I disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 107, pages 110227.
Crossref
Crossref
Teresa Iannaccone, Carmine Sellitto, Valentina Manzo, Francesca Colucci, Valentina Giudice, Berenice Stefanelli, Antonio Iuliano, Giulio Corrivetti & Amelia Filippelli. (2021) Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters. Pharmaceuticals 14:3, pages 204.
Crossref
Crossref
Sandeep Grover, Ajit Avasthi, Rahul Chakravarty, Amitava Dan, Kaustav Chakraborty, Rajarshi Neogi, Avinash Desouza, Omkar Nayak, Samir Kumar Praharaj, Vikas Menon, Raman Deep, Manish Bathla, Alka A. Subramanyam, Naresh Nebhinani, Prosenjit Ghosh, Bhavesh Lakdawala, Ranjan Bhattacharya & AbMajid Gania. (2021) Prescription patterns in clinically stable patients with bipolar disorder: Findings from the Bipolar Disorder Course and Outcome from India (BiD-CoIN) study. Asian Journal of Psychiatry 57, pages 102549.
Crossref
Crossref
Naoto Adachi, Takaharu Azekawa, Kouji Edagawa, Eiichiro Goto, Seiji Hongo, Masaki Kato, Eiichi Katsumoto, Toshiaki Kikuchi, Yukihisa Kubota, Kazuhira Miki, Atsuo Nakagawa, Takashi Tsuboi, Hitoshi Ueda, Koichiro Watanabe, Yoichiro Watanabe, Norio Yasui‐Furukori & Reiji Yoshimura. (2020) Estimated model of psychotropic polypharmacy for bipolar disorder: Analysis using patients' and practitioners' parameters in the MUSUBI study. Human Psychopharmacology: Clinical and Experimental 36:2.
Crossref
Crossref
Jan Scott, Bruno Etain, Andrew Nierenberg & Frank Bellivier. (2020) A taxonomy of clinical response to mood stabilizers. Bipolar Disorders 23:1, pages 24-32.
Crossref
Crossref
Michele Fornaro, Federico Manuel Daray, Fernando Hunter, Annalisa Anastasia, Brendon Stubbs, Domenico De Berardis, Jae Il Shin, Muhammad Ishrat Husain, Elena Dragioti, Paolo Fusar-Poli, Marco Solmi, Michael Berk, Eduard Vieta & André Ferrer Carvalho. (2021) The prevalence, odds and predictors of lifespan comorbid eating disorder among people with a primary diagnosis of bipolar disorders, and vice-versa: Systematic review and meta-analysis. Journal of Affective Disorders 280, pages 409-431.
Crossref
Crossref
Xiaoli Niu, Syvart Dennen, Carole Dembek, Kimberly Laubmeier, Yanmei Liu, Phani Veeranki, Michael Tocco & G. Rhys Williams. (2021) Hospitalization Risk for Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics as Adjunctive Therapy with Mood Stabilizers: A Retrospective Analysis of Medicaid Claims Data. Current Therapeutic Research 94, pages 100629.
Crossref
Crossref
M. Fornaro, A. Anastasia, A. Fusco & Andre Ferrer Carvalho. 2021. Neurobiology of Bipolar Disorder. Neurobiology of Bipolar Disorder
365
372
.
Leona Bessonova, Dawn I. Velligan, Peter J. Weiden, Amy K. O’Sullivan, Aaron Yarlas, Martha Bayliss, Nishtha Baranwal, Kaitlin Rychlec, Julia Carpenter-Conlin, Michael J. Doane & Martha Sajatovic. (2020) Antipsychotic treatment experiences of people with bipolar I disorder: patient perspectives from an online survey. BMC Psychiatry 20:1.
Crossref
Crossref
Michele Fornaro, André F. Carvalho, Andrea Fusco, Annalisa Anastasia, Marco Solmi, Michael Berk, Kang Sim, Eduard Vieta & Andrea de Bartolomeis. (2020) The concept and management of acute episodes of treatment-resistant bipolar disorder: a systematic review and exploratory meta-analysis of randomized controlled trials. Journal of Affective Disorders 276, pages 970-983.
Crossref
Crossref
Ophelia Godin, Marion Leboyer, Yassin Mazroui, Bruno Aouizerate, Jean-Michel Azorin, Belzeaux Raoul, Frank Bellivier, Mircea Polosan, Philippe Courtet, Caroline Dubertret, Chantal Henry, Jean-Pierre Kahn, Josephine Loftus, Emilie Olié, Christine Passerieux, Dominique Costagliola, Bruno Etain, E. Haffen, P.M. Llorca, V. Barteau, S. Bensalem, M. Laaidi, H. Laouamri, K. Souryis, S. Hotier, A. Pelletier, N. Drancourt, J.P. Sanchez, E. Saliou, C. Hebbache, J. Petrucci, L. Willaume, E. Bourdin, M. Carminati, B. Etain, E. Marlinge, J. Meheust, B. Antoniol, A. Desage, S. Gard, A. Jutant, K. Mbailara, I. Minois, L. Zanouy, C. Abettan, L. Bardin, A. Cazals, B. Deffinis, D. Ducasse, M. Gachet, A. Henrion, E. Martinerie, F. Molière, B. Noisette, G. Tarquini, R. Belzeaux, N. Correard, J. L. Consoloni, F. Groppi, L. Lescalier, J. Montant, M. Rebattu, N. Viglianese, R. Cohen, M. Milazzo, O. Wajsbrot-Elgrabli, T. Bougerol, B. Fredembach, S. Garçon, P. Grignon, A. Perrin, A.M. Galliot, I. Grévin, A.S. Cannavo, N. Kayser, P. Roux, V. Aubin, I. Cussac, M.A. Dupont, I. Medecin, N. Mazer & C. Portalier. (2020) Trajectories of functioning in bipolar disorders: A longitudinal study in the FondaMental Advanced Centers of Expertise in Bipolar Disorders cohort. Australian & New Zealand Journal of Psychiatry 54:10, pages 985-996.
Crossref
Crossref
Yoo Hyun Um, Tae-Won Kim, Ho-Jun Seo, Seung-Chul Hong, Sung-Min Kim, Ji-Hye Oh & Jong-Hyun Jeong. (2020) Predictors of 1-year rehospitalization in inpatients with bipolar I disorder treated with atypical antipsychotics. International Clinical Psychopharmacology 35:5, pages 263-269.
Crossref
Crossref
Gudrun Hefner, Jan Wolff, Martina Hahn, Christoph Hiemke, Sermin Toto, Sibylle C. Roll, Thomas Messer & Ansgar Klimke. (2020) Prevalence and sort of pharmacokinetic drug–drug interactions in hospitalized psychiatric patients. Journal of Neural Transmission 127:8, pages 1185-1198.
Crossref
Crossref
Bives Mutume Vivalya, Germain Manzekele Bin Kitoko, Adelard Kalima Nzanzu, Martial Mumbere Vagheni, Rock Kasereka Masuka, Wilson Mugizi & Scholastic Ashaba. (2020) Affective and Psychotic Disorders in War-Torn Eastern Part of the Democratic Republic of the Congo: A Cross-Sectional Study. Psychiatry Journal 2020, pages 1-7.
Crossref
Crossref
Jens Bohlken, Michael Bauer & Karel Kostev. (2020) Drug treatment for patients with bipolar disorders in psychiatric practices in Germany in 2009 and 2018. Psychiatry Research 289, pages 112965.
Crossref
Crossref
Anastasiya Nestsiarovich, Berit Kerner, Aurélien J. Mazurie, Daniel C. Cannon, Nathaniel G. Hurwitz, Yiliang Zhu, Stuart J. Nelson, Tudor I. Oprea, Annette S. Crisanti, Mauricio Tohen, Douglas J. Perkins & Christophe G. Lambert. (2020) Diabetes mellitus risk for 102 drugs and drug combinations used in patients with bipolar disorder. Psychoneuroendocrinology 112, pages 104511.
Crossref
Crossref
Giovani Missio, Doris Hupfeld Moreno, Frederico Navas Demetrio, Marcio Gerhardt Soeiro-de-Souza, Fernando dos Santos Fernandes, Vivian Boschesi Barros & Ricardo Alberto Moreno. (2019) A randomized controlled trial comparing lithium plus valproic acid versus lithium plus carbamazepine in young patients with type 1 bipolar disorder: the LICAVAL study. Trials 20:1.
Crossref
Crossref
Joseph F. Goldberg. (2019) Complex Combination Pharmacotherapy for Bipolar Disorder: Knowing When Less Is More or More Is Better. FOCUS 17:3, pages 218-231.
Crossref
Crossref
. (2019) Evidence-Based Principles for Bipolar Disorder Treatment. FOCUS 17:3, pages 272-274.
Crossref
Crossref
Anastasiya Nestsiarovich, Berit Kerner, Aurélien J. Mazurie, Daniel C. Cannon, Nathaniel G. Hurwitz, Yiliang Zhu, Stuart J. Nelson, Tudor I. Oprea, Mark L. Unruh, Annette S. Crisanti, Mauricio Tohen, Douglas J. Perkins & Christophe G. Lambert. (2019) Comparison of 71 bipolar disorder pharmacotherapies for kidney disorder risk: The potential hazards of polypharmacy. Journal of Affective Disorders 252, pages 201-211.
Crossref
Crossref
Michele Fornaro, Annalisa Anastasia, Alessandro Valchera, Alessandro Carano, Laura Orsolini, Federica Vellante, Gabriella Rapini, Luigi Olivieri, Serena Di Natale, Giampaolo Perna, Giovanni Martinotti, Massimo Di Giannantonio & Domenico De Berardis. (2019) The FDA “Black Box” Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?. Frontiers in Psychiatry 10.
Crossref
Crossref
Luiza Spohr, Mayara Sandrielly Pereira Soares, Pathise Souto Oliveira, Bruna da Silveira de Mattos, Natália Pontes Bona, Nathalia Stark Pedra, Fernanda Cardoso Teixeira, Carlus Augustu Tavares do Couto, Vitor Clasen Chaves, Flávio Henrique Reginatto, Meibel Teixeira Lisboa, Anderson Schwingel Ribeiro, Claiton Leoneti Lencina, Francieli Moro Stefanello & Roselia Maria Spanevello. (2018) Combined actions of blueberry extract and lithium on neurochemical changes observed in an experimental model of mania: exploiting possible synergistic effects. Metabolic Brain Disease 34:2, pages 605-619.
Crossref
Crossref
Gioia Baggiani, Luca Ambrosiani, Pierfranco Trincas, Caterina Burrai & Alberto Bocchetta. (2018) Psychotropic Medication of Acute Episodes of Mood Disorders: Current Prescription Attitude in Two Psychiatric Wards in Cagliari, Italy. Clinical Practice & Epidemiology in Mental Health 14:1, pages 236-249.
Crossref
Crossref
Richard N. Keers, Madalena Plácido, Karen Bennett, Kristen Clayton, Petra Brown & Darren M. Ashcroft. (2018) What causes medication administration errors in a mental health hospital? A qualitative study with nursing staff. PLOS ONE 13:10, pages e0206233.
Crossref
Crossref
Jan Jaracz, Edyta Tetera- Rudnicka, Magdalena Bierejszyk, Kaja Witczyk, Agnieszka Raczyńska, Wojciech Nowak, Anna Pisarczyk, Krzysztof Woźniak, Wojciech Czernaś, Adam Moniakowski & Krystyna Jaracz. (2018) The pattern of pharmacological treatment of bipolar patients discharged from psychiatric units in Poland. Pharmacological Reports 70:4, pages 694-698.
Crossref
Crossref
Michele Fornaro, Annalisa Anastasia, Francesco Monaco, Stefano Novello, Andrea Fusco, Felice Iasevoli, Domenico De Berardis, Nicola Veronese, Marco Solmi & Andrea de Bartolomeis. (2018) Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants. Journal of Affective Disorders 234, pages 131-138.
Crossref
Crossref
Thiago Duarte, Fernanda Barbisan, Pedro Antônio Schmidt do Prado-Lima, Verônica Farina Azzolin, Ivo Emílio da Cruz Jung, Marta Maria Medeiros Frescura Duarte, Cibele Ferreira Teixeira, Moises Henrique Mastella & Ivana Beatrice Mânica da Cruz. (2018) Ziprasidone, a second-generation antipsychotic drug, triggers a macrophage inflammatory response in vitro. Cytokine 106, pages 101-107.
Crossref
Crossref
Michele Fornaro, Annalisa Anastasia, Stefano Novello, Andrea Fusco, Marco Solmi, Francesco Monaco, Nicola Veronese, Domenico De Berardis & Andrea de Bartolomeis. (2018) Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis. Bipolar Disorders 20:3, pages 195-227.
Crossref
Crossref
M. Fornaro, F. Iasevoli, S. Novello, A. Fusco, A. Anastasia, D. De Berardis, A. Valchera & A. de Bartolomeis. (2018) Predictors of hospitalization length of stay among re-admitted treatment-resistant Bipolar Disorder inpatients. Journal of Affective Disorders 228, pages 118-124.
Crossref
Crossref
Jose de Leon & Edoardo Spina. (2018) Possible Pharmacodynamic and Pharmacokinetic Drug-Drug Interactions That Are Likely to Be Clinically Relevant and/or Frequent in Bipolar Disorder. Current Psychiatry Reports 20:3.
Crossref
Crossref
Julia C. Golden, John W. Goethe & Stephen B. Woolley. (2017) Complex psychotropic polypharmacy in bipolar disorder across varying mood polarities: A prospective cohort study of 2712 inpatients. Journal of Affective Disorders 221, pages 6-10.
Crossref
Crossref
Ruziana Masiran & Mohammad Firdaus Abdul Aziz. (2017) Hypertensive bipolar: chronic lithium toxicity in patients taking ACE inhibitor. BMJ Case Reports, pages bcr-2017-220631.
Crossref
Crossref
Yeni Kim, Renata Santos, Fred H. Gage & Maria C. Marchetto. (2017) Molecular Mechanisms of Bipolar Disorder: Progress Made and Future Challenges. Frontiers in Cellular Neuroscience 11.
Crossref
Crossref
Ather Muneer. (2017) Mixed States in Bipolar Disorder: Etiology, Pathogenesis and Treatment. Chonnam Medical Journal 53:1, pages 1.
Crossref
Crossref
Michele Fornaro, Domenico De Berardis, Giampaolo Perna, Marco Solmi, Nicola Veronese, Laura Orsolini, Elisabetta Filomena Buonaguro, Felice Iasevoli, Cristiano André Köhler, André Ferrer Carvalho & Andrea de Bartolomeis. (2017) Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews. BioMed Research International 2017, pages 1-17.
Crossref
Crossref
M. Fornaro, B. Stubbs, D. De Berardis, F. Iasevoli, M. Solmi, N. Veronese, A. Carano, G. Perna & A. De Bartolomeis. (2016) Does the “Silver Bullet” Lose its Shine Over the Time? Assessment of Loss of Lithium Response in a Preliminary Sample of Bipolar Disorder Outpatients. Clinical Practice & Epidemiology in Mental Health 12:1, pages 142-157.
Crossref
Crossref
M. Fornaro, L. Orsolini, S. Marini, D. De Berardis, G. Perna, A. Valchera, L. Ganança, M. Solmi, N. Veronese & B. Stubbs. (2016) The prevalence and predictors of bipolar and borderline personality disorders comorbidity: Systematic review and meta-analysis. Journal of Affective Disorders 195, pages 105-118.
Crossref
Crossref
Michele Fornaro, Brendon Stubbs, Domenico De Berardis, Giampaolo Perna, Alessandro Valchera, Nicola Veronese, Marco Solmi & Licínia Ganança. (2016) Atypical Antipsychotics in the Treatment of Acute Bipolar Depression with Mixed Features: A Systematic Review and Exploratory Meta-Analysis of Placebo-Controlled Clinical Trials. International Journal of Molecular Sciences 17:2, pages 241.
Crossref
Crossref